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Abstract
Background: The right heart often receives less attention during echocardiography. The situation is no different in
septic shock. We prospectively investigated the echocardiographic indices of the right heart in septic shock adult
patients.
Methods: Septic shock ICU patients within 24 h of admission were subjected to transthoracic echocardiography
(TTE) as per the 2005 guidelines from the American Society of Echocardiography.
Results: Eighty-eight septic shock patients (M:F = 52:36) underwent TTE. Thirty-six patients survived. Significant
differences in demographic and biochemical (laboratory and metabolic) parameters, severity scores, life-support
therapies (vasopressors, ventilation), and length of ICU stay were observed between survivors and non-survivors.
Right heart abnormalities of chamber dimension and systolic and diastolic function existed in 79, 25, and 86 % of
patients, respectively. Right ventricle subcostal wall thickness (91 %), pulse Doppler myocardial performance index
(73 %), and E/E′ (63 %) were the predominant abnormalities in chamber dimension, systolic function, and diastolic
function of the right heart, respectively. However, the presence of these abnormalities did not signify poor survival
in our study.
Conclusions: Right heart dimensional and functional abnormalities exist in high proportions in septic shock.
However, their predictability of poor outcomes remains questionable.
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Background
Complex geometry, ill-defined endocardial surface, and
retrosternal right ventricle (RV) impose challenges to im-
aging of the right heart (RH) [1]. This has often resulted
in RH receiving less attention during echocardiography.
Unfamiliarity with optimal ultrasound imaging techniques
and absence of RH data indexed to gender, height, and
weight have only widened the gap. Both transesophageal
echocardiography (TEE) [2–5] and transthoracic echocar-
diography (TTE) [6–10] have been used to study the di-
mensional and functional aspects of RH. Easy and ready
availability of TTE has made it more popular than TEE in
most ICUs. Sepsis is a clinical syndrome caused by severe
infection and is characterized by a systemic inflammation
response syndrome with varying degrees of organ dysfunc-
tion [11]. The entire cardiovascular system is involved in
sepsis and septic shock [12]. However, despite three de-
cades of recognition of sepsis-associated myocardial dys-
function [13], the RH has been studied only sparingly. In a
meta-analysis on severe sepsis and septic shock, only six
studies out of a total of 14 have RH in focus [14].
Amongst these, only two [7, 8] have used TTE. Further-
more, the impact of RH dysfunction during septic shock is
not clear. The absence of a universally accepted definition
of RH dysfunction has only compounded the issue.
Systematic comprehensive quantitative approach to as-
sessment of RH by TTE was given by the American Society
of Echocardiography (ASE) and endorsed by the European
and Canadian Society of Echocardiography [15]. Based on
this approach, we endeavored to explore the impact of RH
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Methods
Baseline clinical characteristics of the study population
The period of our study was from 2012 to 2014. It com-
menced after prior approval from Sanjay Gandhi Post
Graduate Institute of Medical Sciences, ethics commit-
tee. Prior written informed consent was taken from the
patient or next of kin as appropriate. The study included
consecutive septic shock adult patients (≥18 years) ad-
mitted to the ICU of a tertiary care referral hospital and
academic institute in north of India. Septic shock was de-
fined as sepsis with hypotension despite initial volume re-
suscitation in accordance with the American College of
Chest physicians (ACCP)/Society of Critical Care Medicine
(SCCM) Consensus Conference Committee [11].
Relevant demographics [age (years), gender (M:F)];
type of illness [medical (lung-pneumonia, bronchial
asthma, chronic obstructive pulmonary disease), kidney
(acute kidney injury, chronic kidney disease, or acute on
chronic kidney disease), or surgical (postoperative)]; se-
verity scores [acute physiology and chronic health evalu-
ation (APACHE-II) and sequential organ failure
assessment (SOFA)]; laboratory variables; hemodynamic
variables [heart rate, mean arterial pressure (MAP), cen-
tral venous pressure (CVP) in mmHg, central venous
oxygen saturation (CvO2 %) and lactate (mg/dl)]; acid-
base variables [pH, base deficit or excess, partial pres-
sure of arterial oxygen/carbon dioxide (PaO2/PaCO2),
serum electrolytes {sodium (Na+), potassium (K+), chloride
(Cl−)}], fluid balance (previous 24 h, positive/negative);
urine output (UOP) [unaided, aided (diuretic induced or
dialysis supported)] and relevant ICU-specific supportive
therapeutic measures [vasopressors (type and dose),
mechanical ventilation [pressure support (PS) and positive
end-expiratory pressure (PEEP) cmH2O pressure, tidal
volume (ml) and PaO2/FiO2 ratio]; and renal replacement
therapy (RRT)] were recorded. Twenty-eight-day mortality
and free days from event (vasopressor/ventilation/RRT)
during ICU stay were also documented.
Right heart transthoracic echocardiography
A bed side TTE using MicroMaxx Ultrasound System
with P17/5-1 MHz cardiac probe was performed
within the first 24 h of ICU admission in the post-
resuscitation phase of septic shock. Optimal position-
ing for good echocardiographic window of the patient
was ensured before conducting the TTE. The TTE
data was recorded by a trained cardiologist from the
department of cardiology of our institute. Dimensions
averaged over couple of beats were noted. The RH
indices were measured using motion (M)-mode, two-
dimensional (2D) images, and Doppler (pulsed/tissue)
as per ASE guidelines [15]. Left heart (LH) data was
also simultaneously recorded.
Right heart dimensional and functional indices
The chamber dimensions (mm) included: major and
minor dimensions of the right atrium (RA); RA end-
systolic area (ESA, cm2); RV-basal diameter; subcostal
wall thickness; and parasternal short (distal diameter)-
axis/long (proximal diameter)-axis (PSAX/PLAX) out-
flow tract. RV systolic function indices included: tricus-
pid annular plane systolic excursion (TAPSE); pulsed
Doppler (PD) peak velocity at annulus; PD myocardial
performance index (MPI); tissue Doppler (TD) MPI; and
fractional area change (FAC, %). RV diastolic function
indices included: E/A ratio, E/E′ ratio, and deceleration
time (ms). The normal non-indexed reference values
from non-ICU population [15] for the above measures
are displayed in Table 2. RH TTE indices of dimension
or function were further categorized into either normal
or abnormal in relation to available reference normal
values. LH indices of dimension and function were also
measured and left ventricle (LV) systolic dysfunction
was defined as LVEF < 50 % in our study.
Statistical analysis
Statistical analysis was done with SPSS (SPSS Inc.,
Chicago, IL, USA) version 17 for Windows. Data was
expressed as mean ± SD or absolute numbers or propor-
tions as appropriate. Continuous data was compared
using the parametric independent sample t test. Propor-
tion was compared using the Fischer’s exact test. Assess-
ment of correlation between variables was done using
Pearson’s correlation. A probability value of <0.05 (two-
tailed) was considered significant.
Results
Five hundred adult patients were admitted to our ICU
during the study period of 2 years. Out of these, 375,
225, and 150 were in sepsis, severe sepsis, and septic
shock, respectively. We successfully conducted TTE in
59 % (88/150) of septic shock patients. Pre-existing heart
disease, poor echocardiographic window, hemodynamic
instability during optimum positioning, inability to per-
form TTE within first 24 h of ICU admission and refusal
of consent were reasons for exclusion.
Baseline clinical characteristics
The mean age of the study population (N = 88) was
38 ± 15 years with gender (M:F) distribution of 52:36. Fre-
quency of medical illness (91 %; 80/88) in the decreasing
order was as follows: the lung (52 %), renal (41 %), diabetes
mellitus (23 %), and hypertension (11 %), respectively. Base-
line clinical characteristic of all patients are as depicted in
Table 1. Life-support therapies like vasopressors (100 %;
88/88), mechanical ventilation (~88 %; 76/88), and RRT
(~16 %; 14/88) were instituted as appropriate. Mean length
of ICU stay was 21 ± 21 days.
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Table 1 Baseline clinical characteristics of survivors and non-survivors in the post-resuscitation phase of septic shock
Variables Septic shock Survivors Non-survivors P value
(N = 88) (n = 36) (n = 52)
Age, years 38 ± 15 34 ± 13 41 ± 16 0.00*
Gender, female, n (%) 36 (41) 14 (39) 22 (42) 0.83
Type of illness, n (%)
Medical 80 (91) 35 (44) 45 (56) 0.75
Surgical 8 (9) 1 (12) 7 (88) 0.15
Nature of illness, n (%)
Lung disease 46 (52) 14 (39) 32 (61) 0.05
Renal disease 36 (41) 12 (33) 24 (46) 0.27
Comorbid illness, n (%) 34 (39) 14 (41) 20 (59) 1.0
Diabetes mellitus 20 (23) 8 (40) 12 (60) 1.0
Hypertension 10 (11) 4 (40) 6 (60) 1.0
Severity scores
APACHE-II 16.5 ± 7.1 14.6 ± 7.0 17.9 ± 6.9 0.02*
SOFA 10.2 ± 4.5 10.1 ± 4.2 10.3 ± 4.7 0.02*
Laboratory
Hemoglobin, g/dl 10.2 ± 6.5 9.1 ± 2.2 10.9 ± 8.2 0.19
TLC, ×103/μL 17.9 ± 9.5 19 ± 12.1 17.2 ± 7.2 0.06
Platelet, ×103/μL 143 ± 132 160 ± 148 130 ± 97 0.13
Serum creatinine, mg/dl 5.5 ± 2.8 2.4 ± 2.5 7.6 ± 2.6 0.17
Blood urea nitrogen, mg/dl 54.8 ± 42.2 45.1 ± 28.3 61.3 ± 48.4 0.02*
Total bilirubin, mg/dl 4.0 ± 3.5 2.7 ± 1.4 5.3 ± 3.6 0.00*
ALT, U/L 142 ± 130 167 ± 102 124 ± 111 0.37
AST, U/L 160 ± 130 185.4 ± 106.8 141.9 ± 103.5 0.23
ALP, U/L 274 ± 100 353.6 ± 182.1 215.4 ± 136.4 0.47
Albumin, g/dl 2.9 ± 0.7 3.1 ± 0.9 2.7 ± 0.4 0.00*
Hemodynamics
Heart rate, bpm 103 ± 20 100 ± 19 105 ± 22 0.07
MAP, mmHg 87 ± 9 89 ± 11 85 ± 8 <0.001**
CVP, mmHg 8 ± 4 8 ± 3 9 ± 4 0.00*
Central venous O2 saturation, % 73 ± 7 73 ± 6 73 ± 8 0.82
Lactate, mg/dl 18 ± 11 15.9 ± 9 18.9 ± 12.8 0.01*
Acid-base
pH 7.36 ± 0.08 7.38 ± 0.05 7.35 ± 0.10 <0.001**
Base excess 2.4 ± 2.3 1.5 ± 1.3 3.2 ± 2.7 0.00*
Base deficit 4.1 ± 3.4 4.5 ± 3.5 3.9 ± 3.4 0.64
PaO2, mmHg 103 ± 26 104 ± 26 103 ± 26 0.02*
PaCO2, mmHg 42 ± 13 39 ± 7 44 ± 16 0.00*
cHCO3 23.6 ± 5 23 ± 4.1 24 ± 5.6 0.35
Na+, mEq/L 140 ± 8.8 139 ± 10 140 ± 7.8 0.25
K+, mEq/L 4.9 ± 1.6 5.5 ± 0.4 4.4 ± 0.5 0.36
Cl−, mEq/L 101 ± 6.4 100 ± 6.9 102 ± 6.1 0.57
Singh et al. Journal of Intensive Care  (2016) 4:38 Page 3 of 10
Comparison between survivors and non-survivors
Forty-one percent (36/88) of patients survived. Base-
line clinical characteristics of survivors (Ss) and non-
survivors (NSs) are as depicted in Table 1. Significant
difference was observed in the following: age, severity
scores (APACHE-II and SOFA), BUN, bilirubin, albu-
min, MAP, CVP, lactate, pH, base excess, PaO2,
PaCO2, PaO2/FiO2 ratio, pressure support, tidal vol-
ume, hemodynamic support variables, event (ventila-
tion, vasopressor) free days, and length of ICU stay.
Right heart echocardiographic parameters
Seventy (79 %, 70/88) patients with septic shock had
abnormal chamber dimension; while 25 and 86 % had
abnormal systolic and diastolic function, respectively, in
our study. The proportion of these abnormalities and
their respective distribution alone or in various
combinations was as represented in the Venn diagram of
Fig. 1. Also depicted in Fig. 1 is a bar graph showing the
number of patients with simultaneous LV systolic
dysfunction (defined as LVEF < 50 % in this study).
Tables 2 and 3 depict right and left heart TTE indices
of the study population respectively.
Comparison between survivors and non-survivors
Chamber dimensions
In decreasing order, the proportion of abnormal cham-
ber dimensions were as follows: RV subcostal wall thick-
ness ~91 %; RA ESA ~20 %; right ventricular outflow
tract (RVOT)-PSAX distal diameter ~11 %; RV basal
diameter ~9 %; RA minor dimension ~6 %; and RA major
dimension and RVOT-PLAX proximal diameter ~3 %
each. All indices of chamber dimensions were not signifi-
cantly different between Ss and NSs (Table 2).
Table 1 Baseline clinical characteristics of survivors and non-survivors in the post-resuscitation phase of septic shock (Continued)
Mechanical ventilation
Invasive ventilation, n (%) 76 (88) 30 (43) 46 (57) 0.54
PaO2/FiO2 ratio 251 ± 95 254 ± 70 248 ± 109 <0.001**
Pressure support, cmH2O 17 ± 5 17 ± 3 17 ± 6 0.04*
PEEP, cmH2O 8 ± 3 9 ± 2 8 ± 3 0.45
Tidal volume, ml 420 ± 91 459 ± 63 395 ± 97 0.02*
Fluid balance
Last 24 h, ml 1163 ± 940 1418 ± 1028 1009 ± 868 0.60
Positive balance, n (%) 60 (68) 20 (33) 40 (67) 0.19
Negative balance, n (%) 20 (23) 10 (50) 10 (50)
Urine output
Previous 24 h, ml 1461 ± 1058 1658 ± 987 1325 ± 1094 0.16
Unaided, n (%) 50 (57) 22 (44) 28 (56) 0.58
Lasix aided, n (%) 14 (16) 4 (29) 10 (71)
Dialysis, n (%) 14 (16) 6 (43) 8 (57)
Hemodynamic support
Vasopressors, n (%) 88 (100) 36 (44) 52 (56) 0.16
Vasopressin, n (%) 28 (32) 6 (21) 22 (79) 0.02*
NADR dose, μg/kg/min 0.2 ± 0.1 0.10 ± 0.12 0.26 ± 0.26 <0.001**
NADR ≥0.1 μg/kg/min 44 (50) 8 (18) 36 (82) <0.001**
Dobutamine, n (%) 6 (7) 4 (67) 2 (33) 0.22
Event free, days
Ventilation 9 ± 8.5 15.7 ± 15 3.9 ± 6.3 <0.001**
Vasopressor 16.4 ± 15.6 31.4 ± 30.1 5.2 ± 3.7 <0.001**
RRT 21.1 ± 17 32.5 ± 30.5 12.6 ± 11.2 0.06
Length of ICU stay, days 21 ± 21 33.4 ± 30.9 12.1 ± 9.3 0.04*
All measurements are in mean ± SD, unless specified
Abbreviations: APACHE-II acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, ALT alanine
transaminase, AST aspartate aminotransferase, ALP alkaline phosphatase, MAP mean arterial pressure, CVP central venous pressure, PaO2 partial pressure of oxygen,
K+ potassium, Cl− chloride, PEEP positive end-expiratory pressure, NADR noradrenaline, RRT renal replacement therapy, ICU intensive care unit
*Significant, p < 0.05; **highly significant, p < 0.001
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Systolic function
Approximately 25 % (22/88) of patients with septic
shock had abnormal systolic function. In decreasing
order, the proportion of these abnormalities were as fol-
lows: PD-MPI ~73 %; FAC ~54 %; TD-MPI ~36 %; and
TAPSE (mm) ~27 %. Except for FAC (p = 0.04), compari-
son of systolic function indices between Ss and NSs
(Table 2) was non-significant.
Diastolic function
Approximately 86 % (76/88) of patients with septic shock
had abnormal diastolic function. In decreasing order, the
proportion of abnormal RV diastolic function indices were
as follows: E/E′ ratio ~63 %; E/A ratio ~45 %; and
deceleration time ~3 %. The comparisons of the above
diastolic function indices between Ss and NSs amongst
septic shock (Table 2) were non-significant.
Distribution of right heart abnormalities
RH with isolated abnormal chamber dimension and sys-
tolic and diastolic functions was present in 5, 2, and 12 pa-
tients, respectively. A maximum of 44 patients had both
chamber and diastolic function abnormalities, while 8 pa-
tients had all three (chamber and systolic/diastolic) abnor-
malities. All patients with three RH abnormal indices also
had simultaneously similar LH abnormalities. However,
similar distribution was not observed vice versa (Fig. 1).
Fig. 1 Frequency and distribution of right heart abnormalities in septic shock. Numbers in parentheses indicate patients with simultaneous left
heart abnormalities
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Correlation between right and left heart abnormalities
The incidence of LV systolic dysfunction was present in
approximately 23 % (20/88) of septic shock patients.
Within these, 20, 6, and 18 had RH abnormal chamber,
systolic, and diastolic functions, respectively. Significant
correlation was observed between the PD and TD-MPI
of the right and left heart (Fig. 2).
Life-support therapies and right heart echocardiographic
indices
Ventilation
A comparative analysis (table not shown) of ventilated
(n = 76) and non-ventilated (n = 12) patients for RH TTE
indices was not significantly different. Ventilated patients
had a significantly higher noradrenaline dose (p < 0.001)
and urine output (p = 0.007).
Vasopressors
Based on noradrenaline dose of ≥0.1 μg/kg/min, patients
of septic shock were re-categorized (table not shown).
There were 44 patients who required ≥0.1 μg/kg/min
dose. Comparative analysis of RH TTE indices in patients
with (n = 44) and without (n = 44) this dose differed
significantly for FAC (with, 39.67 ± 10.41 vs. without,
38.44 ± 6.4; p = 0.01). At higher doses ≥0.3 μg/kg/min
(n = 22), further significant reduction was observed in
FAC (p < 0.001).
Fluids
Patients with positive (n = 58) and negative (n = 20) fluid
balance (fb) (ml) in the previous 24 h of TTE were com-
pared (table not shown). Significant differences were ob-
served in the following RH indices: RA minor dimension
(positive fb, 27.9 ± 9.9 vs. negative fb, 24.7 ± 3.9; p = 0.039)
and TD-MPI (positive fb, 0.39 ± 0.12 vs. negative fb,
0.34 ± 0.03; p = 0.024).
Discussion
Myocardial depression though well recognized in septic
patients is still poorly understood. Its impact on out-
come still remains debatable [16]. However, despite RH
being equally involved [17], it has been discussed min-
imally in septic shock [7, 8, 18–21]. As of now, no com-
prehensive baseline data of RH in septic shock exists.
Furthermore, there is confusion regarding which single
or constellation of components (chamber dimension,
systolic, and diastolic function) defines acute RH dys-
function [15]. In this context, the present exploratory
study evaluated the impact of RH function on manage-
ment and outcomes in septic shock. To accomplish this,
Table 2 Dimensional and functional echocardiographic parameters of the right heart in septic shock
Dimensional and functional






shock (N = 88)
Septic shock P value 95 % CI of
the differenceSurvivor Non-survivor
(n = 36) (n = 52)
Chamber dimensions
RV basal diameter, mm ≤42 33.12 ± 6.66 32.26 ± 5.03 33.75 ± 7.61 0.41 −03.00 to +01.30
RV SC WT, mm ≤5 6.85 ± 1.56 6.71 ± 1.77 6.95 ± 1.42 0.96 −00.80 to +00.75
RVOT-PSAX distal diameter, mm ≤27 23.77 ± 4.61 23.71 ± 3.22 23.82 ± 5.35 0.42 −00.74 to +01.80
RVOT-PLAX proximal diameter, mm ≤33 24.23 ± 4.98 23.71 ± 3.48 24.57 ± 5.76 0.82 −01.30 to +01.60
RA major dimension, mm ≤53 33.33 ± 8.98 32.67 ± 6.06 33.79 ± 10.57 0.98 −02.70 to +02.70
RA minor dimensions, mm ≤44 26.73 ± 8.74 25.97 ± 8.56 27.26 ± 8.91 0.28 −01.10 to +03.70
RA end-systolic area, cm2 ≤18 16.40 ± 17.05 20.79 ± 25.31 13.23 ± 4.74 0.80 −06.10 to +04.70
Systolic functions
TAPSE, mm ≥16 23.29 ± 5.84 23.56 ± 4.45 23.10 ± 6.67 0.47 −01.10 to +02.40
PD peak velocity at annulus, cm/s ≥10 71.19 ± 22.41 71.50 ± 22.45 70.97 ± 22.62 0.86 −07.00 to +05.90
PD-MPI ≤0.40 0.81 ± 2.81 0.36 ± 0.08 1.12 ± 3.64 0.16 −01.20 to +00.21
TD-MPI ≤0.55 0.39 ± 0.13 0.40 ± 0.13 0.39 ± 0.13 0.33 −00.07 to +00.20
FAC, % ≥35 42.10 ± 8.92 43.25 ± 6.26 41.36 ± 10.26 0.04 00.08 to +06.40
Diastolic functions
E/A ratio 0.8–2.1 1.34 ± 0.64 1.21 ± 0.43 1.43 ± 0.75 0.22 −00.30 to +00.07
E/E′ ratio ≤6 7.75 ± 4.14 7.00 ± 3.67 8.30 ± 4.42 0.17 −02.20 to +00.40
Deceleration time, ms ≥120 164.88 ± 29.22 169.44 ± 26.29 161.60 ± 30.99 0.50 −06.60 to +13.40
Abbreviations: RV right ventricle, RV SC WT RV subcostal wall thickness, RVOT right ventricular outflow tract, PLAX parasternal short-axis, PSAX parasternal long-axis,
RA right atrium, TAPSE tricuspid annular plane systolic excursion, PD pulse Doppler, TD tissue Doppler, MPI myocardial performance index, FAC fractional
area change
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we performed a comprehensive RH TTE in the post-
resuscitation phase of septic shock within the first 24 h
of ICU admission as per established ASE guidelines [15].
The main findings from our study were that RH abnor-
malities (dimensional and functional) exist in high pro-
portion in septic shock patients. Subcostal wall
thickness, PD-MPI, and E/E′ are the predominant ab-
normalities in chamber dimension and systolic and dia-
stolic functions of RV, respectively. However, apparent
differences between Ss and NSs were not statistically sig-
nificant, except for FAC.
Various methods like radionuclide [18], pulmonary ar-
tery catheter [19–21], and TTE [7, 8] have been used for
evaluating the RH. Furthermore, various indices have
been used to describe the dimensional and functional as-
pects of the RH. Included amongst these are ejection
fraction [16–19], stroke volume change [8] for RV func-
tion and end-diastolic volume index [16, 19], diameter
[7], and end-diastolic area [8] for RV dimension. How-
ever, their clinical significance remains questionable [15].
Incidence of RH dysfunction in septic shock is difficult
to estimate in the absence of a well-defined universally
accepted definition. Therefore, we attempted to describe
indices of dimension and function as either normal or
abnormal in comparison to reference values [15].
Discriminative power of RH indices (except FAC) was
not observed in our study. Furian T et al. [7] described
the presence of RV dysfunction (defined by TD peak sys-
tolic velocity [RV-Sm] of <12 cm/s) in severe sepsis as
discriminative between Ss and NSs. Landesberg G et al.
[8] in their study on diastolic dysfunction utilized RV
areas (end-diastolic and -systolic) for the assessment of
RV function in severe sepsis and septic shock and did
not find them differentiating Ss from NSs. In another
study by Landesberg G et al. [22] in 106 patients of se-
vere sepsis and septic shock, authors concluded that RV
systolic dysfunction could explain the association of
troponin with mortality. Using thermodilution technique
in septic shock patients, Vincent JL et al. [20, 21] ob-
served that NSs had lower RVEF. Our study describes
both dimensional and functional aspects of the RH in
complete accordance to ASE guidelines, as against previ-
ous investigators who relied on fewer and lesser stan-
dardized indices. Our results are similar to Landseberg
G et al. [8] but dissimilar to studies by Furian et al. [7],
Vincent et al. [20, 21], and Landesberg G et al. [22]. The
issue whether early ventricular dysfunction or dilatation
decreases mortality in adults with severe sepsis and sep-
tic shock was also explored in a meta-analysis [14].
Huang et al. [14] included more than 700 and 400
Table 3 Dimensional and functional echocardiographic parameters of the left heart in septic shock
Dimensional and functional






shock (N = 88)
Septic shock P value 95 % CI of the
differenceSurvivor Non-survivor
(n = 36) (n = 52)
Chamber dimensions
RV basal diameter, mm ≤42 33.12 ± 6.66 32.26 ± 5.03 33.75 ± 7.61 0.41 −03.00 to +01.30
RV SC WT, mm ≤5 6.85 ± 1.56 6.71 ± 1.77 6.95 ± 1.42 0.96 −00.80 to +00.75
RVOT-PSAX distal diameter, mm ≤27 23.77 ± 4.61 23.71 ± 3.22 23.82 ± 5.35 0.42 −00.74 to +01.80
RVOT-PLAX proximal diameter, mm ≤33 24.23 ± 4.98 23.71 ± 3.48 24.57 ± 5.76 0.82 −01.30 to +01.60
RA major dimension, mm ≤53 33.33 ± 8.98 32.67 ± 6.06 33.79 ± 10.57 0.98 −02.70 to +02.70
RA minor dimensions, mm ≤44 26.73 ± 8.74 25.97 ± 8.56 27.26 ± 8.91 0.28 −01.10 to +03.70
RA end-systolic area, cm2 ≤18 16.40 ± 17.05 20.79 ± 25.31 13.23 ± 4.74 0.80 −06.10 to +04.70
Systolic functions
TAPSE, mm ≥16 23.29 ± 5.84 23.56 ± 4.45 23.10 ± 6.67 0.47 −01.10 to +02.40
PD peak velocity at annulus, cm/s ≥10 71.19 ± 22.41 71.50 ± 22.45 70.97 ± 22.62 0.86 −07.00 to +05.90
PD-MPI ≤0.40 0.81 ± 2.81 0.36 ± 0.08 1.12 ± 3.64 0.16 −01.20 to +00.21
TD-MPI ≤0.55 0.39 ± 0.13 0.40 ± 0.13 0.39 ± 0.13 0.33 −00.07 to +00.20
FAC, % ≥35 42.10 ± 8.92 43.25 ± 6.26 41.36 ± 10.26 0.04 00.08 to +06.40
Diastolic functions
E/A ratio 0.8–2.1 1.34 ± 0.64 1.21 ± 0.43 1.43 ± 0.75 0.22 −00.30 to +00.07
E/E′ ratio ≤6 7.75 ± 4.14 7.00 ± 3.67 8.30 ± 4.42 0.17 −02.20 to +00.40
Deceleration time, ms ≥120 164.88 ± 29.22 169.44 ± 26.29 161.60 ± 30.99 0.50 −06.60 to +13.40
Abbreviations: LV left ventricle, D diastole, S systole, LVWT-IVS LV wall thickness-inter ventricular septum, PW posterior wall, LA left atrium, PD pulse Doppler,
MPI myocardial performance index, TD tissue Doppler, LVEF LV ejection fraction
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patients of the left and right ventricle dysfunction/indi-
ces, respectively, and concluded that there was no statis-
tical difference in RV dimension or function between Ss
and NSs. The findings from our study are in conformity
with this meta-analysis and notably are even more com-
prehensive as they include many newer indices like
TAPSE and PD/TD-MPI of RH.
Correlation between many indices of the right and left
heart was an expected observation. We have only
depicted those with maximum significance. Septic shock
patients invariably require life-support therapies like in-
vasive ventilation, vasopressors, and fluids. Understand-
ing the complex interaction between these factors, either
individually or in combination, along with disease per se
on RH is challenging. Understandably, previous studies
have only minimally explored this issue [14]. Ventilation
increases RH afterload due to increase in pulmonary vas-
cular resistance. In our study, ventilated patients showed
increased chamber dimensions, and reduced systolic and
diastolic functions of RH, though non-significantly. How-
ever, interpretation needs to be cautious as majority of our
patients were ventilated. Vasopressors inevitably have
dose-dependent direct effects on the pulmonary circula-
tion and myocardium. Noradrenaline increases pulmonary
vascular resistance but does not increase RVEF [23]. In
our study, FAC decreased with increasing dose of nor-
adrenaline, probably as a result of dose-dependent in-
crease in pulmonary vascular resistance. However, any
future study on the above issues also needs to analyze the
alterations in RH at various levels, duration, and timing of
vasopressors. Patients with positive fb had higher MPI em-
phasizing the fact that the RH is preload dependent. Most
studies of RH echocardiography in septic shock discuss
minimally about the timing of fluid administration, effect
of vasopressors, and mechanical ventilation [7, 8, 18–21].
Limitations
Preexisting diseases in patients of septic shock, limited
sample size from a single institution, and single snaps
taken in the entire course of septic shock when its onset
is clearly not defined are significant limitations of our
study. Worst cardiac indices may have been missed in
our study despite TTE being performed on the very first
day of ICU admission and apparently also the first day
of septic shock. This is reflected by stable vitals and low
APACHE-II scores in the relatively more stable post-
resuscitation phase of septic shock. Many of the TTE pa-
rameters of RV recorded in this study are difficult to ob-
tain accurately due to problems of either angulation
(e.g., E and E′ velocities of the TV) or irregular shape of
Fig. 2 Correlation between myocardial performance index of the right and left heart
Singh et al. Journal of Intensive Care  (2016) 4:38 Page 8 of 10
RV (e.g., ESA, which depends strongly on the level at
which they are measured) and very thin thickness of RV.
Furthermore, in the absence of repeat TTE, potential re-
versibility of the RH abnormalities could also not be
established. Indexed RH indices are desirable but could
not be performed due to weight-measurement-related is-
sues in our ICU. The absence of provision of TEE in our
study resulted in loss of data in cases wherein TTE
could not be performed due to reasons previously men-
tioned. Comparison of TTE cardiac parameters of ICU
patients with normal non-ICU population may seem un-
justified. However, non-existence of detailed baseline in-
dices as suggested by ASE from ICU patients makes it a
reasonable alternative as of now. Multiple comorbidities
in our study population with underlying pulmonary,
renal, hypertension, and diabetes may not render our
findings generalizable to all populations. The present ex-
ploratory study is only a humble attempt to better
understand RH in septic shock utilizing universally ac-
cepted ASE guidelines. The complex interplay of multi-
factorial aspects of positive intrathoracic pressure, right
atrial pressure, mean systemic filling pressure, RV/LV
cardiac output, pulmonary/systemic vascular resistance,
hypoxic pulmonary vasoconstriction, and RV/LV inter-
dependence in patients of septic shock on vasopressors
is too complicated to comprehend from our study with
abovementioned limitations.
Conclusions
ASE approach to RH assessment allows for better echo-
cardiographic evaluation. Though RH abnormalities exist
in high proportions in patients of septic shock, they did
not predict mortality in our study. While feasibility of
performing TTE for RH function in all septic shock pa-
tients is arguable, efforts should continue to gather more
data from disease-specific patient population. Future
studies should focus on indexing and grading the sever-
ity of RH abnormalities to better objectively classify RH
dysfunction. Future studies with this basic knowledge
may also pave the pathway to better understand complex
heart-lung interactions in positive-pressure-ventilated
patients of septic shock on vasopressors.
Abbreviations
ALP: alkaline phosphatase; ALT: alanine transaminase; APACHE-II: acute
physiology and chronic health evaluation; AST: aspartate aminotransferase; Cl
−: chloride; CVP: central venous pressure; FAC: fractional area change;
ICU: intensive care unit; K+: potassium; MAP: mean arterial pressure;
MPI: myocardial performance index; NADR: noradrenaline; NSs: Non-survivors;
PaO2: partial pressure of oxygen; PEEP: positive end-expiratory pressure;
PLAX: parasternal long-axis; PSAX: parasternal short-axis; RA: right atrium;
RRT: renal replacement therapy; RV: right ventricle; RVOT: right ventricular
outflow tract; Ss: Survivors; SOFA: sequential organ failure assessment;
TAPSE: tricuspid annular plane systolic excursion.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RKS and SK participated in the study design, performed the statistical
analysis, and drafted the manuscript. SN performed the examinations,
collected data, and performed the statistical analysis. AKB, BP, AA, and MG
participated in the study design, performed the statistical analysis, and
revised the manuscript. All authors read and approved the final manuscript.
Acknowledgement
We sincerely acknowledge the help and guidance provided to us by the
departments of cardiology and biostatistics and health informatics of our
institute.
Author details
1Department of Critical Care Medicine, Sanjay Gandhi Post Graduate Institute
of Medical Sciences, Lucknow, Uttar Pradesh 226014, India. 2Department of
Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences,
Lucknow, Uttar Pradesh 226014, India.
Received: 6 April 2016 Accepted: 2 May 2016
References
1. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in
cardiovascular disease, part I: anatomy, physiology, aging, and functional
assessment of the right ventricle. Circulation. 2008;117(11):1436–48.
2. Jardin F, Fourme T, Page B, Loubieres Y, Vieillard-Baron A, Beauchet A, et al.
Persistent preload defect in severe sepsis despite fluid loading: a
longitudinal echocardiographic study in patients with septic shock. Chest.
1999;116(5):1354–9.
3. McLean AS, Huang SJ, Hyams S, Poh G, Nalos M, Pandit R, et al. Prognostic
values of B-type natriuretic peptide in severe sepsis and septic shock. Crit
Care Med. 2007;35(4):1019–26.
4. Etchecopar-Chevreuil C, Francois B, Clavel M, Pichon N, Gastinne H, Vignon
P. Cardiac morphological and functional changes during early septic shock:
a transesophageal echocardiographic study. Intensive Care Med.
2008;34(2):250–6.
5. Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual
incidence of global left ventricular hypokinesia in adult septic shock.
Crit Care Med. 2008;36(6):1701–6.
6. Sturgess DJ, Marwick TH, Joyce C, Jenkins C, Jones M, Masci P, et al.
Prediction of hospital outcome in septic shock: a prospective comparison of
tissue Doppler and cardiac biomarkers. Crit Care. 2010;14(2):R44.
7. Furian T, Aguiar C, Prado K, Ribeiro RV, Becker L, Martinelli N, et al.
Ventricular dysfunction and dilation in severe sepsis and septic shock:
relation to endothelial function and mortality. J Crit Care.
2012;27(3):319.e9-e15.
8. Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, et al.
Diastolic dysfunction and mortality in severe sepsis and septic shock.
Eur Heart J. 2012;33(7):895–03.
9. Pulido JN, Afessa B, Masaki M, Yuasa T, Gillespie S, Herasevich V, et al.
Clinical spectrum, frequency, and significance of myocardial dysfunction in
severe sepsis and septic shock. Mayo Clin Proc. 2012;87(7):620–8.
10. Weng L, Liu YT, Du B, Zhou JF, Guo XX, Peng JM, et al. The prognostic value
of left ventricular systolic function measured by tissue Doppler imaging in
septic shock. Crit Care. 2012;16(3):R71.
11. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al.
Definitions for sepsis and organ failure and guidelines for the use of
innovative therapies in sepsis. The ACCP/SCCM Consensus Conference
Committee. Chest. 2009;136(5):e28.
12. Parrillo JE. Pathogenetic mechanisms of septic shock. New Engl J Med.
1993;328(20):1471–7.
13. McLean AS. Down but not out: myocardial depression in sepsis. Crit Care.
2012;16(3):132.
14. Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation
associated with lower mortality rate in adult severe sepsis and septic shock?
A meta-analysis. Crit Care. 2013;17(3):R96.
15. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K,
et al. Guidelines for the echocardiographic assessment of the right heart in
adults: a report from the American Society of Echocardiography endorsed
by the European Association of Echocardiography, a registered branch of
Singh et al. Journal of Intensive Care  (2016) 4:38 Page 9 of 10
the European Society of Cardiology, and the Canadian Society of
Echocardiography. J Am Soc Echocardiogr. 2010;23:685–13.
16. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in
the patient with sepsis. Curr Opin Crit Care. 2002;8(5):376–88.
17. Hunter JD, Doddi M. Sepsis and the heart. Br J Anaesth. 2010;104(1):3–11.
18. Kimchi A, Ellrodt AG, Berman DS, Riedinger MS, Swan HJ, Murata GH. Right
ventricular performance in septic shock: a combined radionuclide and
hemodynamic study. J Am Coll Cardiol. 1984;4(5):945–51.
19. Dhainaut JF, Lanore JJ, de Gournay JM, Huyghebaert MF, Brunet F, Villemant D,
et al. Right ventricular dysfunction in patients with septic shock. Intensive Care
Med. 1988;14(2):488–91.
20. Vincent JL, Reuse C, Frank N, Contempré B, Kahn RJ. Right ventricular
dysfunction in septic shock: assessment by measurements of right
ventricular ejection fraction using the thermodilution technique. Acta
Anaesthiol Scand. 1989;33(1):34–8.
21. Vincent JL, Gris P, Coffernils M, Leon M, Pinsky M, Reuse C, et al. Myocardial
depression characterizes the fatal course of septic shock. Surgery.
1992;111(6):660–7.
22. Landesberg G, Jaffe AS, Gilon D, Levin PD, Goodman S, Abu-Baih A, et al.
Troponin elevation in severe sepsis and septic shock: the role of left
ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care
Med. 2014;42(4):790–800.
23. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al.
Continuous terlipressin versus vasopressin infusion in septic shock
(TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13:R130.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Singh et al. Journal of Intensive Care  (2016) 4:38 Page 10 of 10
